How did TNXP's earnings trend in 2024?
4/7/2025 07:19pm
Tonix Pharmaceuticals (TNXP) experienced a significant decline in net income in 2024, with a reported loss of $130.04 million for the year ending December 31, 2024. This indicates a challenging financial period for the company.
|code|Ticker|Name|Date|Net Income YoY|Net Income|market_code|
|---|---|---|---|---|---|---|
|TNXP|TNXP.O|Tonix|2024 Q1|54.737161036206636|-1.4939E7|186|
|TNXP|TNXP.O|Tonix|2024 Q2|-177.81069262237267|-7.8776E7|186|
|TNXP|TNXP.O|Tonix|2024 Q3|49.19392314566578|-1.4213E7|186|
|TNXP|TNXP.O|Tonix|2024 Q4|19.083522436132057|-2.2108E7|186|